UCB S.A.UCB S.A.UCB S.A.

UCB S.A.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪23.59 B‬EUR
‪343.00 M‬EUR
‪5.25 B‬EUR
‪117.23 M‬
Beta (1Y)
1.01

About UCB

CEO
Jean-Christophe Tellier
Headquarters
Brussels
Website
Employees (FY)
‪9.08 K‬
Founded
1925
ISIN
BE0003739530
FIGI
BBG000BMYVN7
UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange UCB S.A. stocks are traded under the ticker UNC.
We've gathered analysts' opinions on UCB S.A. future price: according to them, UNC price has a max estimate of 166.00 EUR and a min estimate of 105.00 EUR. Watch UNC chart and read a more detailed UCB S.A. stock forecast: see what analysts think of UCB S.A. and suggest that you do with its stocks.
UNC reached its all-time high on Apr 29, 2024 with the price of 125.06 EUR, and its all-time low was 16.90 EUR and was reached on Oct 27, 2008. View more price dynamics on UNC chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track UCB S.A. financials in yearly and quarterly reports right on TradingView.
UCB S.A. is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
UNC earnings for the last quarter are 1.56 EUR per share, whereas the estimation was 1.34 EUR resulting in a 16.42% surprise. The estimated earnings for the next quarter are 1.34 EUR per share. See more details about UCB S.A. earnings.
UCB S.A. revenue for the last quarter amounts to ‪2.66 B‬ EUR despite the estimated figure of ‪2.54 B‬ EUR. In the next quarter revenue is expected to reach ‪2.37 B‬ EUR.
UNC net income for the last quarter is ‪32.00 M‬ EUR, while the quarter before that showed ‪311.00 M‬ EUR of net income which accounts for −89.71% change. Track more UCB S.A. financial stats to get the full picture.
Yes, UNC dividends are paid annually. The last dividend per share was 0.95 EUR. As of today, Dividend Yield (TTM)% is 0.76%. Tracking UCB S.A. dividends might help you take more informed decisions.
UCB S.A. dividend yield was 1.21% in 2023, and payout ratio reached 52.65%. The year before the numbers were 1.27% and 42.23% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 20, 2024, the company has ‪9.08 K‬ employees. See our rating of the largest employees — is UCB S.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UCB S.A. EBITDA is ‪1.35 B‬ EUR, and current EBITDA margin is 18.47%. See more stats in UCB S.A. financial statements.
Like other stocks, UNC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UCB S.A. stock right from TradingView charts — choose your broker and connect to your account.